Ind Swift Laboratories Ltd (ISLB.BO)
ISLB.BO on Bombay Stock Exchange
43.00INR
17 May 2013
43.00INR
17 May 2013
Price Change (% chg)
Rs-0.70 (-1.60%)
Rs-0.70 (-1.60%)
Prev Close
Rs44.45
Rs44.45
Open
Rs43.20
Rs43.20
Day's High
Rs43.50
Rs43.50
Day's Low
Rs42.80
Rs42.80
Volume
35,788
35,788
Avg. Vol
42,165
42,165
52-wk High
Rs88.50
Rs88.50
52-wk Low
Rs39.10
Rs39.10
ISLB.BO
About
Ind-Swift Laboratories Limited is engaged in the manufacture of Active Pharmaceutical Ingredients (API). The Company operates in a single business segment, Bulk Drugs and Pharmaceuticals. The Company Derabassi facilities manufacturing block include containment facility for high potency drugs, a menthol facility and Power plant.... (more)
No analyst recommendations are available for ISLB.BO.
Overall
| Beta: | 1.31 |
| Market Cap (Mil.): | Rs1,680.78 |
| Shares Outstanding (Mil.): | 39.27 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ISLB.BO | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 2.61 | 35.66 | 35.83 |
| EPS (TTM): | 16.37 | -- | -- |
| ROI: | -- | 19.36 | 18.72 |
| ROE: | -- | 20.07 | 19.54 |
Earnings vs. 
Estimates
No consensus analysis data available.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
